ENTX

Entera Bio Ltd. Ordinary Shares

2.92

USD

-0.10

-3.31%

Oct 23, 15:59 UTC -4

Closed

After-Market

2.91

-0.01

-0.34%

Entera Bio Ltd. Ordinary Shares (ENTX) Earnings

ENTX Earnings Reports

Positive Surprise Ratio

ENTX beat 23 of 31 last estimates.

74%

Next Report

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

-$0.06

Implied change from Q2 26 (Revenue/ EPS)

-57.14%

Implied change from Q3 25 (Revenue/ EPS)

-14.29%

Entera Bio Ltd. Ordinary Shares earnings per share and revenue

On Aug 07, 2026, ENTX reported earnings of -0.14 USD per share (EPS) for Q2 26, missing the estimate of -0.08 USD, resulting in a -71.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.92% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.06 USD, with revenue projected to reach -- USD, implying an decrease of -57.14% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Tiziana Life Sciences Ltd. Common Shares

Report Date

Oct 16, 2026 For Q2 26

Estimate

-$0.08

Actual

-$0.10

Surprise

-22.55%

argenx SE - ADR

Report Date

Oct 22, 2026 For Q3 26

Estimate

$8.19

Actual

$7.80

Surprise

-4.84%

QIAGEN N.V.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.63

Actual

$0.65

Surprise

+2.43%

Nurix Therapeutics, Inc. Common stock

Report Date

Oct 12, 2026 For Q3 26

Estimate

-$0.61

Actual

$4.73

Surprise

+871.74%

FAQ

What were Entera Bio Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Entera Bio Ltd. Ordinary Shares reported EPS of -$0.14, missing estimates by -71.57%, and revenue of $0.00, 0% as expectations.

How did the market react to Entera Bio Ltd. Ordinary Shares's Q2 2026 earnings?

The stock price moved up 5.92%, changed from $2.87 before the earnings release to $3.04 the day after.

When is Entera Bio Ltd. Ordinary Shares expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Entera Bio Ltd. Ordinary Shares's next earnings report?

Based on 3 analysts, Entera Bio Ltd. Ordinary Shares is expected to report EPS of -$0.06 and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.